COVID-19 is once again surging throughout the U.S., but deaths from the disease don’t seem to be following suit. That’s partly because many people have some level of immunity from vaccination or ...
The CDC is warning against using commercial tests to determine immunity. A Centers for Disease Control and Prevention panel once again reminded consumers this week not to use commercial antibody tests ...
That is one of the biggest questions in the world right now, and many people are looking to COVID-19 antibody tests for the answer. These blood tests search for the presence of antibodies against SARS ...
The FDA has issued emergency authorizations to 12 antibody tests for the virus. As federal officials gradually begin reopening the country, expanded testing is central to the conversation. Until now, ...
Monoclonal antibodies target specific disease molecules. They can help treat cancer, autoimmune disorders, and infectious diseases. Discover what you should know about this therapy. Monoclonal ...
NEW YORK (Reuters) - While some potential vaccines have emerged in the global race to find a way to stop the spread of COVID-19, many scientists and researchers believe antibody-based therapies hold ...
Figures from the COVID-19 Infection Survey estimate that nearly 5 million people living in the UK were infected with Covid-19 in the last week of March 2022. Figures also show that 99% of the ...
Most people with scleroderma have autoantibodies. Several scleroderma-specific antibodies have been identified. These can help with diagnosis and give insight into the type of disease you may ...
As part of its Speaking Out video series, CURE spoke with Dr. Lee Greenberger, chief scientific officer of the Leukemia & Lymphoma Society, who discussed recent treatment advancements and FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback